Aliases & Classifications for Mercury Poisoning

MalaCards integrated aliases for Mercury Poisoning:

Name: Mercury Poisoning 20 58 17
Mercury Intoxication 58
Mercury Toxicity 20
Mercurialism 58
Hydrargyria 58

Characteristics:

Orphanet epidemiological data:

58
mercury poisoning
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: All ages; Age of death: any age;

Classifications:



Summaries for Mercury Poisoning

GARD : 20 Mercury poisoning is a condition that occurs in people who are exposed to toxic levels of the element, mercury. There are three different forms of mercury that can cause health problems: Elemental mercury (also known as liquid mercury or quicksilver) can be found in glass thermometers, electrical switches, dental fillings and fluorescent light bulbs. This form of mercury is generally only harmful when small droplets become airborne and are inhaled. If this occurs, signs and symptoms of poisoning may include metallic taste, vomiting, difficulty breathing, coughing, and/or swollen, bleeding gums. In severe cases, long-term brain damage, permanent lung damage and even death may occur. Inorganic mercury is found in batteries, chemistry labs, and some disinfectants. This form of mercury is harmful when swallowed. Signs and symptoms of inorganic mercury poisoning vary based on the amount consumed, but may include burning in the stomach and throat; vomiting; and/or bloody diarrhea. Inorganic mercury can also affect the kidneys and brain if it enters the blood stream. Organic mercury can be found in fish. Some organisms convert fumes from burning coal into organic mercury. This form of mercury is harmful if inhaled, eaten, or placed on the skin for long periods of time. Long-term exposure to organic mercury may result in skin numbness or pain; tremor; inability to walk well; blindness; double vision; memory problems; seizures ; or even death. Treatment is generally supportive and based on the signs and symptoms present in each person. Medications called chelators, which remove mercury and heavy metals from the body, are generally prescribed.

MalaCards based summary : Mercury Poisoning, also known as mercury intoxication, is related to acute kidney failure and nephrotic syndrome. An important gene associated with Mercury Poisoning is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Fluid shear stress and atherosclerosis and Interleukin-4 and 13 signaling. The drugs Metoprolol and Bisoprolol have been mentioned in the context of this disorder. Affiliated tissues include kidney, cortex and eye, and related phenotypes are tremor and hypotension

Wikipedia : 73 Mercury poisoning is a type of metal poisoning due to exposure to mercury. Symptoms depend upon the... more...

Related Diseases for Mercury Poisoning

Diseases in the Mercury Poisoning family:

Infantile Mercury Poisoning

Diseases related to Mercury Poisoning via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 214)
# Related Disease Score Top Affiliating Genes
1 acute kidney failure 30.4 IL18 B2M
2 nephrotic syndrome 30.1 IL18 IL13 B2M
3 acute kidney tubular necrosis 29.9 IL18 B2M
4 brucellosis 29.8 IL18 IL13
5 meningitis 29.6 IL18 IL13
6 gingivitis 29.5 PLAT IL18
7 kidney disease 29.4 THBD IL18 B2M
8 vascular disease 29.1 THBD PLAT IL18
9 thrombocytopenia 28.9 THBD PLAT IL18
10 tremor 11.2
11 infantile mercury poisoning 11.2
12 erythromelalgia 11.2
13 fetal methylmercury syndrome 10.6
14 exanthem 10.4
15 paresthesia 10.3
16 ataxia and polyneuropathy, adult-onset 10.2
17 omphalocele 10.2
18 polyneuropathy 10.2
19 anuria 10.2
20 peripheral nervous system disease 10.2
21 heavy metal poisoning 10.2
22 membranous nephropathy 10.1
23 stomatitis 10.1
24 encephalopathy 10.1
25 autism spectrum disorder 10.1
26 exercise-induced bronchoconstriction 10.1 THBD IL13
27 parkinsonism 10.0
28 pathologic nystagmus 10.0
29 pheochromocytoma 10.0
30 dowling-degos disease 1 10.0
31 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
32 proteinuria, chronic benign 10.0
33 adrenal gland pheochromocytoma 10.0
34 impotence 10.0
35 constipation 10.0
36 sleep disorder 10.0
37 neuropathy 10.0
38 myoclonus 10.0
39 pleural tuberculosis 10.0 IL18 B2M
40 leukocyte disease 10.0 IL13 B2M
41 penicillin allergy 10.0 IL18 IL13
42 latex allergy 10.0 IL18 IL13
43 diabetic polyneuropathy 10.0
44 mycoplasma pneumoniae pneumonia 10.0 IL18 IL13
45 proteasome-associated autoinflammatory syndrome 1 9.9 IL18 IL13
46 bronchiolitis 9.9 IL18 IL13
47 aggressive periodontitis 9.9 IL18 IL13
48 peritonitis 9.9 IL18 B2M
49 autoimmune disease of gastrointestinal tract 9.9 IL18 IL13
50 parasitic protozoa infectious disease 9.9 IL18 IL13

Graphical network of the top 20 diseases related to Mercury Poisoning:



Diseases related to Mercury Poisoning

Symptoms & Phenotypes for Mercury Poisoning

Human phenotypes related to Mercury Poisoning:

58 31 (show all 22)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 tremor 58 31 frequent (33%) Frequent (79-30%) HP:0001337
2 hypotension 58 31 frequent (33%) Frequent (79-30%) HP:0002615
3 hypertension 58 31 frequent (33%) Frequent (79-30%) HP:0000822
4 hypokalemia 58 31 frequent (33%) Frequent (79-30%) HP:0002900
5 anorexia 58 31 frequent (33%) Frequent (79-30%) HP:0002039
6 insomnia 58 31 frequent (33%) Frequent (79-30%) HP:0100785
7 dystonia 58 31 frequent (33%) Frequent (79-30%) HP:0001332
8 respiratory failure 58 31 frequent (33%) Frequent (79-30%) HP:0002878
9 tachycardia 58 31 frequent (33%) Frequent (79-30%) HP:0001649
10 respiratory distress 58 31 frequent (33%) Frequent (79-30%) HP:0002098
11 generalized muscle weakness 58 31 frequent (33%) Frequent (79-30%) HP:0003324
12 abnormality of the cerebral white matter 58 31 frequent (33%) Frequent (79-30%) HP:0002500
13 confusion 58 31 frequent (33%) Frequent (79-30%) HP:0001289
14 loss of consciousness 58 31 frequent (33%) Frequent (79-30%) HP:0007185
15 acute kidney injury 58 31 frequent (33%) Frequent (79-30%) HP:0001919
16 interstitial pneumonitis 58 31 frequent (33%) Frequent (79-30%) HP:0006515
17 episodic abdominal pain 58 31 frequent (33%) Frequent (79-30%) HP:0002574
18 episodic vomiting 58 31 frequent (33%) Frequent (79-30%) HP:0002572
19 nausea 58 31 frequent (33%) Frequent (79-30%) HP:0002018
20 seizure 31 frequent (33%) HP:0001250
21 seizures 58 Frequent (79-30%)
22 dyspnea 58 Frequent (79-30%)

GenomeRNAi Phenotypes related to Mercury Poisoning according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between PTTG1-/- and PTTG1+/+ GR00255-A-4 8.8 B2M IL13 THBD

MGI Mouse Phenotypes related to Mercury Poisoning:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.77 B2M IL13 IL18 PLAT THBD
2 digestive/alimentary MP:0005381 9.72 B2M IL13 IL18 PLAT THBD
3 hematopoietic system MP:0005397 9.65 B2M IL13 IL18 PLAT THBD
4 immune system MP:0005387 9.55 B2M IL13 IL18 PLAT THBD
5 integument MP:0010771 9.35 B2M IL13 IL18 PLAT THBD
6 nervous system MP:0003631 9.02 B2M IL13 IL18 PLAT THBD

Drugs & Therapeutics for Mercury Poisoning

Drugs for Mercury Poisoning (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 90)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metoprolol Approved, Investigational Phase 4 37350-58-6, 51384-51-1 4171
2
Bisoprolol Approved Phase 4 66722-44-9 2405
3
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 11128-99-7, 4474-91-3 172198
4
rituximab Approved Phase 4 174722-31-7 10201696
5 Neurotransmitter Agents Phase 4
6 Adrenergic Antagonists Phase 4
7 Adrenergic Agents Phase 4
8 Antihypertensive Agents Phase 4
9 Omega 3 Fatty Acid Phase 4
10 Anti-Arrhythmia Agents Phase 4
11 Adrenergic beta-Antagonists Phase 4
12 Sympatholytics Phase 4
13 Adrenergic beta-1 Receptor Antagonists Phase 4
14 Immunoglobulins Phase 4
15 Antibodies Phase 4
16 Immunoglobulin A Phase 4
17 Antineoplastic Agents, Immunological Phase 4
18 Giapreza Phase 4
19 Immunoglobulins, Intravenous Phase 4
20 Angiotensinogen Phase 4
21 Angiotensin-Converting Enzyme Inhibitors Phase 4
22 Antirheumatic Agents Phase 4
23 Angiotensin Receptor Antagonists Phase 4
24
Timolol Approved Phase 3 26839-75-8 33624 5478
25
Bimatoprost Approved, Investigational Phase 3 155206-00-1 5311027
26
Latanoprost Approved, Investigational Phase 3 130209-82-4 5282380 5311221
27
Succimer Approved Phase 3 304-55-2 9354
28
Formaldehyde Approved, Vet_approved Phase 3 50-00-0 712
29
Diltiazem Approved, Investigational Phase 3 42399-41-7 39186
30
tannic acid Approved Phase 3 1401-55-4
31
Nicardipine Approved, Investigational Phase 3 55985-32-5 4474
32
Labetalol Approved Phase 3 36894-69-6 3869
33
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
34
Urapidil Investigational Phase 3 34661-75-1
35 Chelating Agents Phase 3
36 Pharmaceutical Solutions Phase 3
37 Ophthalmic Solutions Phase 3
38 Antidotes Phase 3
39 Protective Agents Phase 3
40 Vaccines Phase 3
41 Immunologic Factors Phase 3
42 Hemagglutinins Phase 3
43 Gentamicins Phase 3
44 Vasoconstrictor Agents Phase 3
45 Vasodilator Agents Phase 3
46 calcium channel blockers Phase 3
47 Hormones Phase 3
48 Calcium, Dietary Phase 3
49
Calcium Nutraceutical Phase 3 7440-70-2 271
50
Petrolatum Approved, Investigational Phase 2 8009-03-8

Interventional clinical trials:

(show all 41)
# Name Status NCT ID Phase Drugs
1 Blood Mercury Levels Following Retrograde Amalgam Surgeries Completed NCT01428609 Phase 4
2 Validation of a Hybrid Blood Pressure Monitor to Replace the Mercury Standard for Validation Studies According to Modified Criteria of the European Society of Hypertension International Protocol 2010 Completed NCT01120990 Phase 4
3 Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients (CREATIVE Study) Completed NCT01508325 Phase 4 Bisoprolol;Metoprolol
4 A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy Completed NCT00498368 Phase 4 Intravenous Rituximab;ACE/ARB
5 A Prospective, Multi-center, Open-label, Single Arm Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II DIAbetic patieNTs With Suboptimal Blood Pressure Control (GIANT Study) Completed NCT01066039 Phase 4 Bisoprolol
6 A Prospective, Double-masked, Randomized, Multicenter, Active-controlled, Parallel-group, 6-month Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution Compared to GANFORT® (Bimatoprost 0.03% / Timolol 0.5%) Ophthalmic Solution in Subjects With Elevated Intraocular Pressure (MERCURY 3) Completed NCT03284853 Phase 3 Netarsudil/Latanoprost 0.02%/0.005%;GANFORT®
7 Treatment of Lead-Exposed Children (TLC) Trial Completed NCT00342849 Phase 3 Succimer;Placebo
8 A Phase III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 65 Years and Above Recruiting NCT04548518 Phase 3
9 A Double-blinded, Randomized Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of N1, N3-bis-(2-Mercaptoethyl) Isophthalamide (NBMI) in the Reduction of Mercury Levels, in Subjects Exposed to Mercury in Atlántico, Colombia Not yet recruiting NCT04183595 Phase 2, Phase 3 (N1, N3-bis(2- mercaptoethyl)isophthalamide)
10 Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage Terminated NCT01176565 Phase 3 Intravenous nicardipine hydrochloride
11 A Randomized, Placebo-controlled Study to Explore Safety, Dose and Efficacy of NBMI in a Mercury Intoxicated Population Completed NCT02486289 Phase 2 Emeramide;Placebo
12 Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study Completed NCT02028208 Phase 2
13 An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder Withdrawn NCT00376194 Phase 2 DMSA
14 Transdermal Absorption of DMPS and Its Effect on Urinary Mercury Excretion Completed NCT01059474 Phase 1 transdermal DMPS
15 Environmental Contaminants and Infant Development Completed NCT00013858
16 Brainwave Control of a Wearable Robotic Arm for Rehabilitation and Neurophysiological Study in Cervical Spine Injury Completed NCT02443558
17 Cross-over Clinical Trial to Assess the Effectiveness of Applying Dry Local Heat and/ or High Tourniquet Pressure With Current Clinical Practice for Venipuncture, and Blinded for Evaluating Their Impact on Hemolysis Completed NCT04027218
18 Assessment of Mercury Levels and Metabolism in Premature and Low Birth Weight (LBW) Infants Receiving Vaccines Containing Thimerosal Completed NCT00138333
19 Consuming Fish to Reduce Mercury Intake While Optimizing Omega-3 Fatty Acid Status Completed NCT01123759
20 Comparison of Manual Blood Pressure Monitoring Using a Mercury Sphygmomanometer to an Automated Blood Pressure Instrument in a Research Setting Completed NCT01753895
21 A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy Completed NCT00809666
22 Heavy Metals (Cadmium, Lead, Mercury, Zinc), Angiogenesis Factors (Endostatin, Angiostatin, VEGF) and Osteopontin in Patients With Coronary Artery Disease Completed NCT02159235
23 Association Between HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in the Egyptian Population Completed NCT03839979
24 A Pilot Randomized Controlled Trial to Promote Healthful Fish Consumption in Pregnancy Completed NCT01126762
25 C-MAC Compared to Direct Laryngoscopy in Patients With Immobilized Cervical Spine by Unexperienced Physicians: A Randomized Crossover Manikin Trial Completed NCT02733536
26 Validation of the YuWell YE900 Medical Electronic Blood Pressure Monitor in Adults and Children According to the AAMI/ESH/ISO 81060-2:2018 Standard Completed NCT04379323
27 Assessing the Accuracy of the A&D TM-2657W Oscillometric Device Completed NCT04238442
28 24-hour Blood Pressure Measurements and Ischemic Conditioning Completed NCT03303404
29 VEINEX : Venous Investigations During Exercise Completed NCT02689557
30 A Controlled, Open-Label, Randomized Study to Evaluate the Application of Negative Pressure to the Periocular Microenvironment to Alter Pattern Electroretinography Readings by Way of Modulating Intraocular Pressure Recruiting NCT04433702
31 NeuroPRotective Effect of remOte Ischemic condiTioning in Ischemic strokE Treated With meChanical Thrombectomy (PROTECT-I Study) Recruiting NCT03915782
32 Levels of Selected Microelements in Premature Ovarian Insufficiency Recruiting NCT04767451
33 Analysis of Some Heavy Metals and Some Vitamins Levels in Maternal Samples, Fetal Samples and Breast Milk for Fetal Growth Restriction. Recruiting NCT04394611
34 Does Remote Ischemic Limb Preconditioning Improve Cerebral Vasomotor Reactivity in Healthy Volunteers? Recruiting NCT02553655
35 Microbial Mechanisms of Methylmercury Metabolism in Humans Active, not recruiting NCT04060212
36 A Pilot Study of the Effect of Dietary Sodium Intake on Assessments of Vascular Endothelium Active, not recruiting NCT01550315
37 Effect of Low Intensity Strength Training Combined With Moderate Blood Flow Restriction on Muscle Vasodilatation and Arterial Stiffness in Elders With Low Gait Velocity. Active, not recruiting NCT03272737
38 Validation of Wrist Type Oscillometric Blood Pressure Monitorings Not yet recruiting NCT04633785
39 Cigarette Harm Reduction With Electronic Cigarette Use Not yet recruiting NCT03473483
40 Prazosin as an Antimanic Agent in Severe Mania or Mixed Episodes: a Double-blind, Placebo-controlled Study Withdrawn NCT01621165 Addition of prazosin to usual care (add-on study);Placebo
41 An Open Label, Clinical Performance Study to Demonstrate the Clinical Accuracy of the Smartphone Vital Signs System (SVSS) Withdrawn NCT02199457

Search NIH Clinical Center for Mercury Poisoning

Genetic Tests for Mercury Poisoning

Anatomical Context for Mercury Poisoning

MalaCards organs/tissues related to Mercury Poisoning:

40
Kidney, Cortex, Eye, Skeletal Muscle, Thyroid, Pituitary, Whole Blood

Publications for Mercury Poisoning

Articles related to Mercury Poisoning:

(show top 50) (show all 1509)
# Title Authors PMID Year
1
Changes in the renal function after acute mercuric chloride exposure in the rat are associated with renal vascular endothelial dysfunction and proximal tubule NHE3 inhibition. 61
33476711 2021
2
Immune-associated neuromyotonia syndrome following mercury poisoning. 61
33067679 2021
3
Nitric oxide donor, sodium nitroprusside, mitigates mercury toxicity in different cultivars of soybean. 61
33383453 2021
4
Mercury and selenium concentrations in the crab Callinectes arcuatus from three coastal lagoons of NW Mexico. 61
33106905 2021
5
Acute mercury toxicity and bioconcentration in shrimp Litopenaeus vannamei juveniles: Effect of low salinity and chemical speciation. 61
33333299 2021
6
Pentadecanuclear Fe-Containing Polyoxometalate Catalyst for Visible-Light-Driven Generation of Hydrogen. 61
33621075 2021
7
A scoping review of sources of mercury and its health effects among Pakistan's most vulnerable population. 61
32822319 2021
8
Mercury Toxicity and Detection Using Chromo-Fluorogenic Chemosensors. 61
33562543 2021
9
Neurobehavioral and immune-toxic impairments induced by organic methyl mercury dietary exposure in Nile tilapia Oreochromis niloticus. 61
33264694 2021
10
Evaluation of dietary selenium, vitamin C and E as the multi-antioxidants on the methylmercury intoxicated mice based on mercury bioaccumulation, antioxidant enzyme activity, lipid peroxidation and mitochondrial oxidative stress. 61
33497984 2021
11
Biomonitoring selenium, mercury, and selenium:mercury molar ratios in selected species in Northeastern US estuaries: risk to biota and humans. 61
33471308 2021
12
Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism. 61
33561145 2021
13
Congenital Minamata disease: a description of two cases in Niigata. 61
33741117 2020
14
Disseminated pulmonary emboli caused by mercury: A rare consequence of Munchausen's syndrome. 61
33364013 2020
15
Chronic mercury poisoning causing back pain in spondyloarthritis: a case report. 61
32591827 2020
16
Palmoplantar eruption in a patient with mercury poisoning. 61
33465192 2020
17
Mercury toxicity in pregnant and lactating rats: zinc and N-acetylcysteine as alternative of prevention. 61
32671705 2020
18
Acute Elemental Mercury Poisoning Masquerading as Fever and Rash. 61
32572678 2020
19
Warmer temperature increases mercury toxicity in a marine copepod. 61
32544748 2020
20
Imaging Hg2+-Induced Oxidative Stress by NIR Molecular Probe with "Dual-Key-and-Lock" Strategy. 61
32786484 2020
21
Sulfhydryl groups as targets of mercury toxicity. 61
32905350 2020
22
One man's swordfish story: The link between Alzheimer's disease and mercury exposure. 61
32951747 2020
23
[Clinical study of sequential glucocorticoids in the treatment of acute mercury poisoning complicated with interstitial pneumonia]. 61
32892595 2020
24
Visualizations of Mercury Methylation and Dynamic Transformations by In Vivo Imaging. 61
32638515 2020
25
[A misdiagnosis case of kidney damage caused by mercury poisoning]. 61
32746582 2020
26
Autoimmune Manifestations of Acute Mercury Toxicity. 61
32281400 2020
27
Environmental Toxic Exposures Using Companion Animals as an Indicator of Human Toxicity: A Case Report and Discussion. 61
32532580 2020
28
The chemical species of mercury accumulated by Pseudomonas idrijaensis, a bacterium from a rock of the Idrija mercury mine, Slovenia. 61
32032872 2020
29
Effect of soil mercury pollution on ginger (Zingiber officinale Roscoe): Growth, product quality, health risks and silicon mitigation. 61
32199219 2020
30
Mechanistic Investigations of Nickamine- catalyzed Hydrosilylation of Alkenes: Nickel Nanoparticles Are the Active Species. 61
32560749 2020
31
Survey of Methylmercury Exposures and Risk Factors Among Indigenous Communities in Guyana, South America. 61
32509405 2020
32
Bargain with the tooth fairy - The savings accounts for dental stem cells. 61
32333995 2020
33
Mercury, cadmium, copper, arsenic, and selenium measurements in the feathers of adult eastern brown pelicans (Pelecanus occidentalis carolinensis) and chicks in multiple breeding grounds in the northern Gulf of Mexico. 61
32297009 2020
34
Metalloproteomic approach of mercury-binding proteins in liver and kidney tissues of Plagioscion squamosissimus (corvina) and Colossoma macropomum (tambaqui) from Amazon region: Possible identification of mercury contamination biomarkers. 61
31812405 2020
35
Knowledge and Attitude of Dentists and Patients Toward Use and Health Safety of Dental Amalgam in Saudi Arabia. 61
32396969 2020
36
A Minimal Membrane Metal Transport System: Dynamics and Energetics of mer Proteins. 61
31721253 2020
37
Rethinking the Minamata Tragedy: What Mercury Species Was Really Responsible? 61
31951385 2020
38
Mercury Poisoning From Skin Cream. 61
32044950 2020
39
Aluminum and vaccines: Current state of knowledge. 61
31611133 2020
40
All that glitters is not gold: Mercury poisoning in a family mimicking an infectious illness. 61
32151591 2020
41
[Heavy metals in the enviroment: Guillain-Barre like syndrome]. 61
31984709 2020
42
Evaluation of Dietary Organic and Inorganic Mercury Threshold Levels on Induced Mercury Toxicity in a Marine Fish Model. 61
32121390 2020
43
Genomics of Detoxification: How Genomics can be Used for Targeting Potential Intervention and Prevention Strategies Including Nutrition for Environmentally Acquired Illness. 61
32027241 2020
44
Prenatal exposure to legacy contaminants and visual acuity in Canadian infants: a maternal-infant research on environmental chemicals study (MIREC-ID). 61
32028962 2020
45
An unusual cause of high density radiological opacities. 61
32383469 2020
46
Association between acute severe mercury poisoning and multiple organ failure. 61
32913510 2020
47
Nephrotic syndrome caused by exposures to skin-lightening cosmetic products containing inorganic mercury. 61
31314603 2020
48
Broken thermometer in foot: a source of mercury poisoning. 61
31694474 2020
49
Deforestation Due to Artisanal and Small-Scale Gold Mining Exacerbates Soil and Mercury Mobilization in Madre de Dios, Peru. 61
31825606 2020
50
Changes of 30 years in the recognized occupational diseases of Korea: Lessons from the system change perspective. 61
30741113 2020

Variations for Mercury Poisoning

Expression for Mercury Poisoning

Search GEO for disease gene expression data for Mercury Poisoning.

Pathways for Mercury Poisoning

Pathways related to Mercury Poisoning according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.55 THBD PLAT
2 11.43 IL18 IL13
3
Show member pathways
11.37 IL18 B2M
4 11.16 IL18 IL13
5 10.85 IL18 IL13
6 10.46 IL18 IL13
7 10.07 IL18 IL13

GO Terms for Mercury Poisoning

Cellular components related to Mercury Poisoning according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.33 THBD PLAT B2M
2 external side of plasma membrane GO:0009897 9.13 THBD IL13 B2M
3 extracellular space GO:0005615 9.02 THBD PLAT IL18 IL13 B2M

Biological processes related to Mercury Poisoning according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of cold-induced thermogenesis GO:0120162 9.26 IL18 IL13
2 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.16 IL18 IL13
3 immune response GO:0006955 9.13 IL18 IL13 B2M
4 positive regulation of smooth muscle cell proliferation GO:0048661 8.62 IL18 IL13

Sources for Mercury Poisoning

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....